Search clinical trials for: CC-5013 (lenalidomide)
Total 1918 results
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Recurrent Childhood Pilocytic Astrocytoma | Recurrent Childhood Visual Pathway GliomaUnited States, Canada, Australia, New Zealand
-
CelgeneCompletedChronic Lymphocytic Leukemia | Leukemia, B-Cell, ChronicCanada, United States, Germany, Italy, Spain, Sweden, United Kingdom
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Alkylating Agent-Related Acute Myeloid LeukemiaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Adult Acute Myeloid Leukemia in RemissionUnited States
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, Germany
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
CelgeneCompletedMultiple MyelomaUkraine, Russian Federation
-
King's College Hospital NHS TrustCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
National Cancer Institute (NCI)WithdrawnChronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
Celgene CorporationCompletedRadiculopathyUnited States
-
National Cancer Institute (NCI)CompletedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
Celgene CorporationTerminatedComplex Regional Pain Syndrome, Type IUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Waldenstrom... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Childhood Myelodysplastic Syndromes | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With... and other conditionsUnited States
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
Celgene CorporationPrologue Research InternationalCompletedNon-Small Cell Lung CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
CelgeneCompleted
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterCelgeneCompletedLeukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLLUnited States
-
Washington University School of MedicineCompletedLeukemia, Myeloid, AcuteUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFatigue | Thrombocytopenia | Fever | Chronic Lymphocytic Leukemia | Lymphadenopathy | Small Lymphocytic Lymphoma | Hypogammaglobulinemia | Lymphocytosis | Night Sweats | ParaproteinemiaUnited States
-
Celgene CorporationCompletedCrohn's DiseaseFrance, United States, United Kingdom, Israel
-
CelgeneCompleted
-
CelgeneCompletedMultiple MyelomaUnited States
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Celgene CorporationCompletedMelanoma | Neoplasm MetastasisUnited States, Canada
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedAnemia | Chronic Myelomonocytic Leukemia | Adult Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent B-Cell Prolymphocytic Leukemia | Refractory B-Cell Prolymphocytic LeukemiaUnited States
-
University of California, DavisCelgeneCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
CelgenePrologue Research InternationalCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Brian JonasNational Cancer Institute (NCI); Celgene; Pharmacyclics LLC.CompletedPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Therapy-Related Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic SyndromeUnited States
-
CelgeneCompletedMyelodysplastic SyndromeSpain, United Kingdom, Denmark, Germany, France, Greece, Italy, Sweden, Belgium, United States, Luxembourg, Norway
-
M.D. Anderson Cancer CenterCompleted
-
CelgeneICON Clinical ResearchCompletedMelanoma | Neoplasm MetastasisAustralia, United Kingdom, Ukraine, Germany, Estonia, Latvia, Lithuania, Netherlands, South Africa
-
Jason Robert GotlibCelgene CorporationTerminatedLeukemia | Anemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
The Christie NHS Foundation TrustCelgene Corporation; Leukemia Research FundTerminatedChronic Lymphocytic LeukaemiaUnited Kingdom
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Light Chain Deposition DiseaseUnited States, Puerto Rico, Ireland
-
M.D. Anderson Cancer CenterActive, not recruitingSmoldering Plasma Cell MyelomaUnited States
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States, Canada
-
Gesellschaft fur Medizinische Innovation - Hamatologie...ClinAssess GmbHCompleted
-
Mayo ClinicNational Cancer Institute (NCI); Novartis PharmaceuticalsCompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States